Core 2 - Animal Models of Inflammatory Disease Core
Core 2 - Animal Models of Inflammatory Disease Core
批准号:
8688897
负责人:
MATTHEW J FLICK
金额:
$12.6万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal Disease ModelsAnimal ExperimentationAnimal ModelAnti-Cytokine TherapyArthritisAutoimmune DiseasesAutoimmune ProcessBiochemicalBiological ModelsClinical ResearchCollagen ArthritisCommunitiesComplementComplexDNADermatomyositisDevelopmentDiseaseDisease ProgressionES Cell LineEncephalomyelitisEtiologyEuropeanGene ExpressionGene TargetingGenerationsGenesGenotypeGoalsHumanHuman PathologyImmuneImmunologyInflammatoryInformaticsJointsK/BxN modelKnock-in MouseKnock-outKnockout MiceMHC Class I GenesMaintenanceMediatingMicroscopicMissionModelingMultiple SclerosisMusMutagenesisMutationMyositisPediatric HospitalsProcessPropertyReagentResearchResearch PersonnelRheumatismSerumSeverity of illnessSystemTNF geneTechnical ExpertiseTechnologyTestingTherapeuticTimeTissuesTransgenic ModelTransgenic Organismsautoimmune arthritisbasecytokinedesignembryonic stem cellgain of functiongene discoverygenetic technologyhuman subjectin vivointerestloss of functionmembermouse genomemouse modelprogramsprospectivetoolvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The over-arching mission of the Animal Models of inflammatory Disease Core is to support investigators of the Cincinnati Children's Hospital Research Community in the use of experimental animal settings of rheumatic diseases, autoimmune diseases, and inflammatory processes. In so doing, the Core will promote advances in the understanding and treatment of arthritic and auto-inflammatory diseases. Animal models, particularly those involving murine systems, have emerged as powerful tools in arthritis and autoimmune research due to the fact that any gene identified as a candidate "disease modifier" can be easily manipulated in mice through either "gene-targeting" or standard transgenic technologies. In providing an in vivo experimental system amenable to investigator-imposed genetic alterations (e.g., loss-of-function or gain-of function), animal models offer the unique opportunity (not available in human subjects) to test hypotheses focused on identifying the fundamental mechanisms that drive auto-inflammatory disease. Animal models offer the ability of collecting entire tissues (i.e., whole joints) for detailed analyses of biochemical, immunological, pathological and gene expression properties, and as well as performing comprehensive temporal analyses of disease progression. The utility of animal models has been highlighted by the fact that these experimental systems have often provided the early proof-of-principle for some of the most powerful therapeutic strategies (e.g., anti-cytokine therapies such as TNF blockers). Finally, many animal models of arthritis and other auto-inflammatory diseases are available with distinct etiologies (e.g., adaptive immune driven vs. cytokine driven), and thus provide a variety of distinct frameworks to study these complex disease processes. The Specific Aims of the Animal Models of Inflammatory Diseases Core are to (i) provide technical expertise and starter reagents to investigators interested in animal models of auto-inflammatory disease (i.e., arthritis, neuroinflammatory disease, and dermatomyositis), and (ii) provide material assistance in the generation and characterization of both transgenic and gene-targeted mice that will be instructive with regard to the development and progression of auto-inflammatory disease. This core serves as the perfect complement to ongoing basic and clinical studies (e.g., immunology, informatics, and gene discovery) of the Cincinnati Rheumatic Diseases Core Center Research Base.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
-
批准号:10681313
-
项目类别:
-
资助金额:$92.8万
-
财政年份:2022
-
负责人:MATTHEW J FLICK
-
依托单位:
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
-
批准号:10517972
-
项目类别:
-
资助金额:$95.67万
-
财政年份:2022
-
负责人:MATTHEW J FLICK
-
依托单位:
2022 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Seminar
-
批准号:10386008
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2021
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
-
批准号:10471424
-
项目类别:
-
资助金额:$55.17万
-
财政年份:2021
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
-
批准号:10676149
-
项目类别:
-
资助金额:$54.28万
-
财政年份:2021
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
-
批准号:10316657
-
项目类别:
-
资助金额:$58.03万
-
财政年份:2021
-
负责人:MATTHEW J FLICK
-
依托单位:
Fibrin(ogen) control of metabolic inflammation and obesity
-
批准号:10311076
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2018
-
负责人:MATTHEW J FLICK
-
依托单位:
Fibrin(ogen) control of metabolic inflammation and obesity
-
批准号:10065070
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2018
-
负责人:MATTHEW J FLICK
-
依托单位:
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
-
批准号:10458582
-
项目类别:
-
资助金额:$83.42万
-
财政年份:2018
-
负责人:MATTHEW J FLICK
-
依托单位:
Fibrin(ogen) control of metabolic inflammation and obesity
-
批准号:10083730
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2018
-
负责人:MATTHEW J FLICK
-
依托单位:
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
-
批准号:10022502
-
项目类别:
-
资助金额:$85.51万
-
财政年份:2018
-
负责人:MATTHEW J FLICK
-
依托单位:
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
-
批准号:10017669
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2017
-
负责人:MATTHEW J FLICK
-
依托单位:
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
-
批准号:10439615
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2017
-
负责人:MATTHEW J FLICK
-
依托单位:
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
-
批准号:9380727
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2017
-
负责人:MATTHEW J FLICK
-
依托单位:
Hemostatic factors and sickle cell disease
-
批准号:8972027
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the hemostatic protease thrombin to arthritic disease
-
批准号:8522260
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2009
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the hemostatic protease thrombin to arthritic disease
-
批准号:7741348
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2009
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the hemostatic protease thrombin to arthritic disease
-
批准号:7911684
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2009
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the hemostatic protease thrombin to arthritic disease
-
批准号:8302981
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2009
-
负责人:MATTHEW J FLICK
-
依托单位:
Mechanisms linking the hemostatic protease thrombin to arthritic disease
-
批准号:8118197
-
项目类别:
-
资助金额:$26.17万
-
财政年份:2009
-
负责人:MATTHEW J FLICK
-
依托单位:
海外基金